Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Combo of 3 Antibiotics Can Kill Deadly Staph Infections

September 28, 2015 1:44 pm | News | Comments

Three antibiotics that, individually, are not effective against a drug-resistant staph infection can kill the deadly pathogen when combined as a trio, according to new research. Read more...


Two-Drug Combo Helps Older Adults with Hard-to-Treat Depression

September 28, 2015 1:35 pm | News | Comments

More than half of older adults with clinical depression don't get better when treated with an antidepressant. But results from a multicenter clinical trial that included Washington University School of Medicine in St. Louis indicates that adding a second drug — an antipsychotic medication — to the treatment regimen helps many of those patients. Read more...


BMS’s Nivolumab (Opdivo) Extends Survival Rate in Lung, Kidney Cancer

September 28, 2015 1:09 pm | by Stephanie Guzowski, Editor | News | Comments

New studies of the cancer drug nivolumab (Opdivo), presented this weekend at the European Cancer Congress in Vienna, showed positive results: extending the lives of patients with advanced lung cancer for several months, and treating patients with advanced kidney cancer more effectively than the current standard treatment. Read more...


Scholar Rock Touts Muscle-Building Drug's Potential

September 28, 2015 11:09 am | by Ryan Bushey, Associate Editor | News | Comments

The company revealed new data regarding lead drug candidate SRK-015 last week at the European Molecular Biology Organization’s annual meeting. Read more...


New Drug Target Could Shed Light on Opioid Addiction

September 28, 2015 9:47 am | by Bevin Fletcher, Associate Editor, Bioscience Technology | News | Comments

Researchers from The Scripps Research Institute in Florida, may have zeroed in a protein that could be a new drug target for developing less-addictive pain medications. Read more...


Oncology Leads Development in Promising Gene Therapy Pipeline

September 28, 2015 8:12 am | by Dominic Trewartha, Managing Analyst, GBI Research | News | Comments

​Despite few products having so far reached the market and captured strong revenues, the gene therapy pipeline remains large, with 906 products in active development across all stages. Read more...


American Doctor Cured of Ebola Continues His Work in Liberia

September 28, 2015 8:00 am | by Philip Marcelo, Associated Press | News | Comments

This time last year, Dr. Rick Sacra was given a second chance at life. Read more...


Diabetes Drug Could Help Treat Alcohol Addiction

September 28, 2015 7:45 am | by University of Gothenburg | News | Comments

A new study on mice and rats at Sahlgrenska Academy shows that a medication used for diabetes and obesity also could be a valuable tool for the treatment of alcohol dependence. Read more...


India-Based Company Doesn't Want Drug Used for Executions

September 28, 2015 7:30 am | by Claudia Lauer, Associated Press | News | Comments

An India-based company that appears to have made a drug that Arkansas purchased for lethal injections said it doesn't want its products used in the state's plans. Read more...


Roche's Advanced Melanoma Treatment Recommended for EU Approval

September 28, 2015 7:15 am | News | Comments

Approximately 50 percent of melanoma skin cancers are BRAF-positive, and more than 55,000 people worldwide die every year from melanoma. Read more...


Novartis' Entresto Recommended for EU Approval

September 28, 2015 7:00 am | News | Comments

Heart failure is a highly debilitating, life-threatening condition in which the heart cannot pump enough blood around the body. Read more...


Regeneron and Icahn School of Medicine at Mount Sinai Announce New Antibody Research Agreement

September 25, 2015 11:48 am | News | Comments

Regeneron Pharmaceuticals, Inc. and The Experimental Therapeutics Institute (ETI) at the Icahn School of Medicine at Mount Sinai today announced that they have entered into an agreement with the goal of accelerating the discovery of fully human antibodies directed against therapeutic targets being researched by Mount Sinai investigators. Read more...


Drug Discovery Spotlight: This Week's Most Hated Man in America?

September 25, 2015 11:22 am | by Stephanie Guzowski, Editor | News | Comments

Welcome to Drug Discovery Spotlight, where we’ve rounded up this week’s most popular headlines. Read more...


CVS Sells Heroin Overdose Antidote OTC in 14 States

September 25, 2015 11:10 am | by Ryan Bushey, Associate Editor | News | Comments

The retailer hopes to make Narcan available at more locations within the next few months. Read more...


Molecular 'Feedback Loop' May Explain Tamoxifen Resistance in Patients with Breast Cancer

September 25, 2015 9:48 am | by Johns Hopkins University | News | Comments

For reasons unknown, many patients with breast cancer treated with the estrogen receptor-blocking drug tamoxifen eventually become resistant to the treatment despite the fact that their cancer cells still have the estrogen receptor proteins that the drug normally targets. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.